Clinical Trials
10 trialsNCT04182100 2025-09-15
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
PharmaEssentia Japan K.K.
Phase 2 Completed
NCT06290765 2025-07-31
PV
PharmaEssentia
Phase 4 Not yet recruiting
NCT02274662 2025-01-16
Expanded Access Protocol Thymus Transplantation
Sumitomo Pharma Switzerland GmbH
Phase 4 Completed
NCT06002490 2024-11-08
A Study to Evaluate P1101 in Japanese PV Patients
PharmaEssentia Japan K.K.
Phase 3 Completed
NCT02781272 2023-06-05
EMBER
Angle plc
Completed
NCT03884400 2022-11-14
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
iSpecimen Inc
Withdrawn
NCT03706235 2020-07-14
NOVA
Clinical Genomics Pathology
Completed
NCT02785731 2018-11-09
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Angle plc
Completed
NCT00133900 2009-07-28
IMMC-38
Immunicon
Unknown
NCT00133913 2008-03-19
IMMC-06
Immunicon
Unknown